Award
CanadaBuys #W6369-20A009
Amend 010 - BioThrax Vaccine - Emergent BioDefense Operations Lansing LLC
Recipient
Emergent BioDefense Operations Lansing
Award Amount
$36,996,123.20
Ceiling
$36,996,123.20
Awarded
October 25, 2019
Identifier
W6369-20A009
Award for Anthrax Vaccine contract to Emergent BioDefense Operations Lansing valued at CAD 36,996,123.20 for 125 months.
Description
Contract awarded for Anthrax Vaccine - Biothrax to Emergent BioDefense Operations Lansing. The contract duration is 125 months from 2019/10/25 to 2030/03/31 with a total value of CAD 36,996,123.20. The contract is under the Canadian Free Trade Agreement (CFTA) and was awarded due to Exclusive Rights.